| Literature DB >> 35563853 |
Philipp Burt1,2, Rebecca Cornelis1, Gustav Geißler1,2, Stefanie Hahne1, Andreas Radbruch1, Hyun-Dong Chang1,3, Kevin Thurley1,2,4.
Abstract
Memory plasma cells constitutively produce copious amounts of antibodies, imposing a critical risk factor for autoimmune disease. We previously found that plasma cell survival requires secreted factors such as APRIL and direct contact to stromal cells, which act in concert to activate NF-κB- and PI3K-dependent signaling pathways to prevent cell death. However, the regulatory properties of the underlying biochemical network are confounded by the complexity of potential interaction and cross-regulation pathways. Here, based on flow-cytometric quantification of key signaling proteins in the presence or absence of the survival signals APRIL and contact to the stromal cell line ST2, we generated a quantitative model of plasma cell survival. Our model emphasizes the non-redundant nature of the two plasma cell survival signals APRIL and stromal cell contact, and highlights a requirement for differential regulation of individual caspases. The modeling approach allowed us to unify distinct data sets and derive a consistent picture of the intertwined signaling and apoptosis pathways regulating plasma cell survival.Entities:
Keywords: apoptosis; cell signaling; immunological memory; mathematical model; plasma cells
Mesh:
Substances:
Year: 2022 PMID: 35563853 PMCID: PMC9102437 DOI: 10.3390/cells11091547
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 7.666
Antibodies used for flow-cytometric measurement of apoptosis proteins.
| Antibody Clone | Manufacturer | Catalog nr. |
|---|---|---|
| Anti-mouse BCL-2, REA356 | Miltenyi Biotec | Catalog # 130-105-474 |
| Anti-mouse BIM, 14A8 | Milipore | Catalog # MAB17001 |
| Anti-mouse CD138, REA104 | Miltenyi Biotec | Catalog # 130-102-318 |
| Anti-mouse MCL-1, Y37 | Abcam | Catalog # ab32087 |
| Anti-mouse NOXA, 114C307 | Abcam | Catalog # ab13654 |
Figure 1Regulation of plasma cell survival via APRIL and ST2. (A) Schematic signal integration of ST2 and APRIL. How the signals are integrated into the BAX-dependent apoptosis network is yet unclear. Time course data were taken from Ref. [12] and are here represented as Box plots. Data were fitted to exponential curves, each experiment at a time (Supplementary Figure S1). Curves shown here represent mean + s.e.m. of those fit results. BAX* denotes activated BAX. (C) Average half-lives of each condition based on the fitting procedure from (B). ** p < 0.01, *** p < 0.001, n > 12 fits per condition. Error bars represent standard deviation.
Figure 2A mechanistic model quantifies the BAX-dependent apoptosis network in plasma cells. (A) Geometric mean of measured core proteins in APRIL/ST2/APRIL + ST2 environments normalized to the respective concentration without stimulus (Medium) (n = 6 biological replicates). (B) Ratios of indicated proteins taken from (A) after normalization to Medium condition. (C) Model scheme. APRIL- and ST2-induced PI3K signal via NF-κB and FoxO, thereby affecting BCL-2 family protein abundance data, as shown in panel A. The model includes pro-apoptotic proteins BIM and NOXA (red) and anti-apoptotic proteins BCL-2 and MCL-1 (green). BAX* denotes activated BAX. (D) Protein ratios (see A) fitted to the model shown in panel B (). Error bars represent standard deviation. (E) Model fit to survival kinetics (Figure 1B) after fitting the protein ratios (). (F) Time-course simulation of the mechanistic apoptosis model for different inputs as indicated.
Parameter values used in the mathematical models.
| Parameter | Value | Unit | Role | Source |
|---|---|---|---|---|
| aBCL-2 | 0.11 | - | Effect APRIL on gBCL-2 | Fit |
| sMCL-1 | 0.37 | - | Effect ST2 on gMCL-1 | Fit |
| sBCL-2 | 0.53 | - | Effect ST2 on gBCL-2 | Fit |
| sBIM | 0.49 | - | Effect ST2 on gBIM | Fit |
| sNOXA | 0.40 | - | Effect ST2 on gNOXA | Fit |
| γ | 0.43 | d−1 | Max. effect size BAX* | Fit |
| κ | 1.78 | - | Max. effect Caspase 12 | Fit |
| β | 2.65 | - | Inhibition strength ST2 on Caspase 3,7 | Fit |
| dMCL-1 | 16.4 | d−1 | Decay rate MCL-1 | [ |
| dBCL-2 | 0.86 | d−1 | Decay rate BCL-2 | [ |
| dBIM | 5.94 | d−1 | Decay rate BIM | [ |
| dNOXA | 32.8 | d−1 | Decay rate NOXA | [ |
| dBAX | 1.38 | d−1 | Decay rate BAX | [ |
| Kd,3 | 2.0 | nM | Dissociation constant | [ |
| Kd,4 | 22.0 | nM | Dissociation constant | [ |
| Kd,5 | 40.0 | nM | Dissociation constant | [ |
| Kd,6 | 2.50 | nM | Dissociation constant | [ |
| Kd,7 | 68.0 | nM | Dissociation constant | [ |
| k+ | 0.17 | µM d−1 | Complex association rate | - |
| k1 | 43.2 | µM d−1 | BAX activation rate | - |
| k2 | 8.64 | µM d−1 | BAX* deactivation rate | - |
| gp,0 | 0.86 | µM d−1 | Basal protein growth | - |
| α | 10.0 | - | Inhibition strength APRIL on Caspase 12 | - |
| KBAX | 200 | nM | Half-saturation constant BAX-half-life | - |
Figure 3Unifying the data sets on MCL-2 family members and plasma cell survival data requires direct regulation of caspases. (A) Model scheme, combination of the mechanistic mitochondrial apoptosis model (see Figure 2B) with ER-stress-induced caspase activation. (B,C) Combined model fit to protein data and survival kinetics (). Error bars represent standard deviation. (D) Effect on half-life for simulated partial inhibition or overexpression of BAX/BCL-2-family proteins and caspases 3, 7, and 12. Parameters were varied by one order of magnitude with respect to the best-fit parameter value. (E) Effect of quantitative inhibition or overexpression of NF-κB, PI3K, and apoptotic regulators on half-life. Parameters were varied as 2-, 5-, or 10-fold change with respect to the best-fit parameter value.
Figure 4All considered regulatory processes are required to explain the data. (A) Different hypothetic network topologies (ii–vi) as submodules of the model shown in (3A), here presented as a condensed version (i). Abbreviations: M2: Model 2; A: APRIL; S: ST2; C12: Caspase 12; C3/7: Caspase 3, Caspase 7. Model components removed from the full model are shown in red. (B) goodness-of-fit (1/root-mean-squared error)) for each submodel (ii–vi). (C) Akaike information criterion (−ΔAIC) for each sub-model compared to the full model (i), where the model with smallest −ΔAIC is used as a reference and set to 0.